what glp is retatrutide Research Guide: the Phase 2 Trial Data Reported (2026) GLP-3 R 30mg - Apollo

Description

For anyone concerned about maintaining muscle during GLP-1 therapy, combining medication with adequate protein intake and resistance training is essential regardless of which medication is used

Hernan, M

The Science Behind Retatrutide Retatrutide is a once-weekly subcutaneous injection developed by Eli Lilly that engages three hormonal pathways central to appetite regulation, metabolism, and energy balance: GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows gastric emptying, and improves glycemic control

One side effect that gets people asking questions: dysesthesia TRIUMPH4 reporting mentions dysesthesia (odd, uncomfortable sensations like tingling/burning) and says it was generally mild and infrequently led to discontinuation